The BCL-2 apoptosis regulator (BCL-2) and BCL-2 like 1 (BCL-XL) proteins have been proven to be critical apoptosis inhibitors that are closely correlated with cancer chemoresistance by regulating apoptosis, proliferation, differentiation, and tumor progression [16, 17]. This evidence concerns the gene BCL2L1 and cancer.